AzTrials
AzTrials

Abdominal Wall DefectNCT04644965

Evaluation of the Motor Activity, Cardiopulmonary Performance Capacity and Quality of Life in Patients Born With a Congenital Abdominal Wall Defect

An observational study of Abdominal Wall Defect, run by Medical University of Graz at 1 site in Austria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The two most common congenital abdominal wall defects (AWD) are gastroschisis and omphalocele. Prenatal detection is often possible and the defects are differentiated by the presence or absence of a sac around the eviscerated organs. Read more about this study

Who is it for?
Ages 6 to 18 years
Conditions the study is for
Abdominal Wall Defect
What is being tested?
CombynTM Function & Spaces ECG, Blood Taking and Spiroergometry
How many people
20 participants
Where
1 siteAustria
Study dates
5 Oct 2020to 31 May 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 18 years
  • All sexes
  • Child, Adult

Study population: All patients born with an abdominal wall defect between 6-18years old are invited personally for examinations.

Who may be able to join

  • All patients born with an abdominal wall defect

Who cannot join

  • mental disease

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • Medical University of Graz

    Graz, Styria, 8036

Other trials in Austria

About this study

The two most common congenital abdominal wall defects (AWD) are gastroschisis and omphalocele. Prenatal detection is often possible and the defects are differentiated by the presence or absence of a sac around the eviscerated organs. A omphalocele occurs in 0.6-4.8 in 10,000 live births compared to 4.5 in 10,000 live births with gastroschisis. In the last years a rising incidence of gastroschisis has been shown worldwide.

Both forms of AWDs necessitate early surgical intervention, mostly in one or two stages, and support at an intensive care unit in the first days of life. Additionally, patients need parenteral feeding in the first weeks of life. The outcome depends on the size of the defect and on the associated malformations.

Read more

The literature about long-term outcome of these malformations is scarce. Some publications have reported long-term complications like redo-surgical procedures because of fascial gaps or umbilical or incisional hernias. Furthermore, stool irregularities, abdominal pain and several admission to the hospital due to ileus or sub-ileus have been described. Additionally, half of the patients are unsatisfied with the cosmetic result.

Some other studies have shown that children born with an AWD have the same quality of life (QoL) compared with the healthy community.

Nevertheless, patients with AWDs need a standardized, structured and multimodal long-time follow-up program to be able to detect any problems early and give advice to understand their illness in order to achieve the same QoL as healthy children.

Therefore, the aim of this dissertation will be:

  • to prospectively assess the motor activity, cardiopulmonary performance capacity and QoL of patients treated with AWDs in our Department
  • to suggest a new standardized follow-up protocol for patients born with an AWD
Being tested
CombynTM Function & Spaces ECG, Blood Taking, Spiroergometry, Dordel Koch Test (DKT), Ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CombynTM Function & Spaces ECGDiagnostic test

    Multi-frequency impedance measurement to assess the muscle and fat mass

  • Blood TakingDiagnostic test

    Sampling of blood of the finger pad to assess liver function

  • SpiroergometryDiagnostic test

    Spiroergometry to assess cardiopulmonary capacity. The intensity will be raised in steps until total exhaustion. In between each step we will take blood of the ear lobe to determine the lactate level

  • Dordel Koch Test (DKT)Diagnostic test

    Dordel Koch Test (DKT) to evaluate the motor activity. The DKT is a heterogeneous test battery for children and adolescents and consists of seven parts: lateral jumping, sit and reach, situps, long stand jump, one-legged stand, push-ups and 6-min-run

  • UltrasoundDiagnostic test

    Ultrasound for abdominal wall muscles

  • Stance and gait analysesDiagnostic test

    Stance and gait analyses for measuring the core stability

Study groups in NCT04644965
Study groupRoleWhat they receive
Abdominal Wall Defectpatients born with an abdominal wall defect
Receives: Diagnostic Test: CombynTM Function & Spaces ECG; Diagnostic Test: Blood Taking; Diagnostic Test: Spiroergometry; Diagnostic Test: Dordel Koch Test (DKT); Diagnostic Test: Ultrasound; Diagnostic Test: Stance and gait analyses
Control Groupage and sex matched Control Group
Receives: Diagnostic Test: CombynTM Function & Spaces ECG; Diagnostic Test: Blood Taking; Diagnostic Test: Spiroergometry; Diagnostic Test: Dordel Koch Test (DKT); Diagnostic Test: Ultrasound; Diagnostic Test: Stance and gait analyses

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Motor Activity

    Comparison of the Dordel Koch Test between the two groups. (T-Test or Mann-Withney-U)

    Measured: 30 minutes

  2. Cardiopulmonary Performance Capacity - lung function

    Comparing relative lung function [%] between the two groups.(T-Test or Mann-Withney-U)

    Measured: 30 minutes

  3. Cardiopulmonary Performance Capacity - peak VO2

    Comparing peak VO2 between the two groups.(T-Test or Mann-Withney-U)

    Measured: 30 minutes

  4. Gastrointestinal Quality of Life

    Gastrointestinal Quality of Life Index (GIQLI): most desirable option: 4 points, least desirable option: 0 points GIQLI score: sum of the points - Score Range: 0-148 Compare the mean between the two groups (T-Test or Mann-Withney-U)

    Measured: 15 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2020
  2. Study start5 Oct 2020
  3. Primary completion28 Feb 2021
  4. Study completion31 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04644965
Sponsor's protocol ID
32-231 ex 19/20
Status last verified
Jan 2023
First submitted
19 Nov 2020
Last updated
5 Oct 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Frybova B, Kokesova A, Zemkova D, Mixa V, Vlk R, Rygl M. Quality of life in patients with gastroschisis is comparable with the general population: A questionnaire survey. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Mar;161(1):75-79. doi: 10.5507/bp.2016.059. Epub 2016 Dec 13.

    PubMed 27982137
  • Snoep MC, de Heus R, Manten GTR, Lap CCMM, Snoeker BAM, Lindeboom MYA. Gastro-intestinal function and quality of life are favorable in adolescent and adult gastroschisis patients. Early Hum Dev. 2020 Feb;141:104936. doi: 10.1016/j.earlhumdev.2019.104936. Epub 2019 Dec 23.

    PubMed 31874371
  • Harris EL, Minutillo C, Hart S, Warner TM, Ravikumara M, Nathan EA, Dickinson JE. The long term physical consequences of gastroschisis. J Pediatr Surg. 2014 Oct;49(10):1466-70. doi: 10.1016/j.jpedsurg.2014.03.008.

    PubMed 25280647
  • Kaiser MM, Kahl F, von Schwabe C, Halsband H. [Omphalocele and gastroschisis. Outcome--complications--follow-up--quality of life]. Chirurg. 2000 Oct;71(10):1256-62. doi: 10.1007/s001040051212. German.

    PubMed 11077588

Questions about this trial

What is this clinical trial studying?

An observational study of Abdominal Wall Defect, run by Medical University of Graz at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Motor Activity (time frame: 30 minutes). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04644965, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in